332 - Would the discussion of the bioequivalence of a particular product be considered to be a non-pharmacologic claim? If the piece included bioequivalence data (and no other claims) would the lowest level of fair balance suffice?
Jennifer Carroll last edited by
Claims of bioequivalence are pharmacokinetic in nature. A piece containing only such claims (with the indication) would require middle level fair balance.